Treatment of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: the cardiovascular system

被引：34

作者：

Barendrecht, MM

Koopmans, RP

De La Rosette, JJMCH

Michel, MC

机构：

[1] Univ Amsterdam, Acad Med Ctr, Dept Pharmacol & Pharmacotherapy, NL-1105 AZ Amsterdam, Netherlands

[2] Univ Amsterdam, Dept Urol, NL-1105 AZ Amsterdam, Netherlands

[3] Univ Amsterdam, Dept Internal Med, NL-1105 AZ Amsterdam, Netherlands

来源：

BJU INTERNATIONAL | 2005年 / 95卷

关键词：

LUTS; BPH; alpha(1)-adrenoceptor antagonists; blood pressure; adverse events; cardiovascular diseases; antihypertensives; phosphodiesterase inhibitors;

D O I：

10.1111/j.1464-410X.2005.05487.x

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：19 / 28

页数：10

共 80 条

[1] TAMSULOSIN, A SELECTIVE ALPHA(1C)-ADRENOCEPTOR ANTAGONIST - A RANDOMIZED, CONTROLLED TRIAL IN PATIENTS WITH BENIGN PROSTATIC OBSTRUCTION (SYMPTOMATIC BPH) [J].

ABRAMS, P ;

SCHULMAN, CC ;

VAAGE, S ;

ABEL, P ;

BAXBY, K ;

BOEMINGHAUS, F ;

DELAERE, KPJ ;

DENIS, L ;

DIJKMAN, GA ;

HASSELLUND, S ;

HOHENFELLNER, R ;

JANKNEGT, RA ;

KAPPER, BJ ;

KARTHAUS, HFM ;

KHOE, GSS ;

KIL, PJM ;

KROMANNANDERSEN, B ;

LELIEFELD, HHJ ;

LOCK, TMTW ;

MOHR, M ;

MOMMSEN, S ;

OGREID, P ;

OTTO, RW ;

PLASMAN, JWMH ;

PULL, HC ;

RYTTOV, N ;

TOLLEY, DA ;

VENEMA, PL ;

WYNDAELE, JJ ;

YPMA, AFGVM .

BRITISH JOURNAL OF UROLOGY, 1995, 76 (03) :325-336

[2] Simultaneous administration of vardenafil and tamsulosin does not induce clinically significant hypotension in patients with benign prostatic hyperplasia [J].

Auerbach, SM ;

Gittelman, M ;

Mazzu, A ;

Cihon, F ;

Sundaresan, P ;

White, WB .

UROLOGY, 2004, 64 (05) :998-1003

[3] Lower urinary tract symptoms and erectile dysfunction: Co-morbidity or typical "aging male" symptoms? Results of the "Cologne male survey [J].

Braun, MH ;

Sommer, F ;

Haupt, G ;

Mathers, MJ ;

Reifenrath, B ;

Engelmann, UH .

EUROPEAN UROLOGY, 2003, 44 (05) :588-594

[4]

Brawer M K, 1993, Arch Fam Med, V2, P929, DOI 10.1001/archfami.2.9.929

[5]

Buzelin JM, 1997, EUR UROL, V31, P190

[6] Comparison of tamsulosin with alfuzosin in the treatment of patients with lower urinary tract symptoms suggestive of bladder outlet obstruction (symptomatic benign prostatic hyperplasia) [J].

Buzelin, JM ;

Fonteyne, E ;

Kontturi, M ;

Witjes, WPJ ;

Khan, A .

BRITISH JOURNAL OF UROLOGY, 1997, 80 (04) :597-605

[7]

CAINE M, 1976, BRIT J UROL, V48, P255, DOI 10.1111/j.1464-410X.1976.tb03013.x

[8]

Chapple CR, 1996, EUR UROL, V29, P155

[9] Initiation of nonselective alpha1-antagonist therapy and occurrence of hypotension-related adverse events among men with benign prostatic hyperplasia:: A retrospective cohort study [J].

Chrischilles, E ;

Rubenstein, L ;

Chao, J ;

Kreder, KJ ;

Gilden, D ;

Shah, H .

CLINICAL THERAPEUTICS, 2001, 23 (05) :727-743

[10] Effects of heat stress on baroreflex function in humans [J].

Crandall, CG ;

Cui, J ;

Wilson, TE .

ACTA PHYSIOLOGICA SCANDINAVICA, 2003, 177 (03) :321-328

← 1 2 3 4 5 6 7 8 →